The life expectancy of WAS patients is limited and death occurs after bleeding, recurrent infections or malignancies. At present, WAS patients can be kept alive for over 10 years by conventional ...
The development of gene therapies for the treatment of cancer has generally relied upon two strategies. The first is the expression of a therapeutic transgene from a replication-defective (RD) viral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback